BIG PHARMA EARNINGS WATCH: MERCK, NOVARTIS & PFIZER

10-28-2020 Blog Posts

Brand Name Drug Companies Beat Wall Street Expectations After Repeatedly Hiking Prices New earnings reports for the third quarter of 2020 show that Big Pharma giants are continuing to rake in profits while hiking prescription drug prices. On Tuesday, Big Pharma drug companies Merck, Novartis and Pfizer announced earnings for the third quarter that bested […]

ICYMI: BIG PHARMA’S PANDEMIC PRICE HIKES AND PATENT ABUSE UNDERSCORE URGENCY FOR ACTION

10-28-2020 Blog Posts

Big Pharma’s Pandemic Price Hikes and Patent Abuse Underscore Urgency for Action By Lauren Aronson Morning Consult October 28, 2020 https://morningconsult.com/opinions/big-pharmas-pandemic-price-hikes-and-patent-abuse-underscore-urgency-for-action/ Before the COVID-19 pandemic, more than 58 million Americans struggled to afford their prescription drugs. Now, the economic impact of the health crisis continues to leave millions of American workers, families and seniors struggling […]

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

10-13-2020 Blog Posts

Price Hikes Fuel Q3 Earnings Beat For Brand Name Giant As millions of Americans continue to grapple with the economic impact of the COVD-19 pandemic, the first earnings report for the second quarter of 2020 from a Big Pharma giant demonstrates that hiking prices on American patients continues to be a profitable practice for the […]

SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD INCREASE OOP COSTS AND PREMIUMS FOR SENIORS — DO NOTHING TO LOWER RX PRICES

10-5-2020 Blog Posts

Big Pharma Claims Misguided Proposal Would Benefit Patients, Facts Show It Would Hand Drug Companies a More Than $100 Billion Bailout During a recent POLITICO webinar “Solving America’s Drug Pricing Puzzle,” Kristen Bernie, Deputy Vice President of Policy and Research for PhRMA, claimed the misguided Rebate Rule would benefit American patients. “I would argue that the executive […]

THEY SAID IT: LAWMAKERS EXPOSE BIG PHARMA’S EGREGIOUS PRICE HIKES AND ANTI-COMPETITIVE TACTICS — DEBUNK BLAME GAME AND EXCUSES

10-1-2020 Blog Posts

Lawmakers Blast Big Pharma Executives During Two-Day Hearing on “Unsustainable Drug Prices,” Demonstrate Bipartisan Commitment to Hold Drug Companies Accountable This week, the U.S. House Committee on Oversight and Reform held two days of hearings on “Unsustainable Drug Prices.” Executives from brand name drug manufacturers including Bristol Myers Squibb, Amgen and Novartis were grilled for […]

DOSE OF REALITY: LAWMAKERS RIGHT TO TRAIN RENEWED FOCUS ON BIG PHARMA’S PRICE-GOUGING AND ANTI-COMPETITIVE TACTICS

09-29-2020 Blog Posts

Brand Name Drug Companies Must be Held Accountable for Pandemic Price Hikes And Egregious Practices During U.S. House Committee on Oversight and Reform Hearing AN OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE The U.S. House of Representatives Committee on Oversight and Reform is scheduled to hold two days of hearings with Big Pharma executives this week […]

ICYMI: LA TIMES – VACCINE MAKER GOT $1 BILLION FROM TAXPAYERS. NOW IT’S BOOSTING DRUG PRICES

09-15-2020 Blog Posts

Brand Name Drug Maker AstraZeneca Aggressively Raised Prices In The Middle Of A Pandemic, Even While Receiving Hundreds Of Millions In Taxpayer Funding Vaccine Maker Got $1 Billion From Taxpayers. Now It’s Boosting Drug Prices Los Angeles Times Noam N. Levey September 14, 2020 https://www.latimes.com/politics/story/2020-09-14/drug-maker-got-1-billion-from-taxpayers-boosting-prices One of the world’s largest drug companies has been aggressively […]

ICYMI: STUDY SHOWS BIG PHARMA’S ANTI-COMPETITIVE GAMESMANSHIP COMES AT TREMENDOUS COST TO U.S. HEALTHCARE SYSTEM

09-14-2020 Blog Posts

Report Finds Just Five Instances Of Product Hopping Sticks Americans With $4.7 Billion Price Tag In case you missed it, a new study by Alex Brill of Matrix Global Advisors (MGA), commissioned by the Coalition for Affordable Prescription Drugs (CAPD), demonstrates the tremendous cost to the U.S. healthcare system from just one of the many […]

ICYMI: REPORT CONFIRMS REBATE RULE WOULD HIKE PREMIUMS, COST TAXPAYERS BILLIONS OF DOLLARS AND BOOST “DRUG COMPANY REVENUES”

09-8-2020 Blog Posts

Study Finds Rebates Negotiated By PBMs Reduce Rx Costs and Lower Premiums – Eliminating Rebates Would Increase Costs On American Seniors & Taxpayers, While Handing Big Pharma a Bailout In case you missed it, a new report by Alex Brill of Matrix Global Advisors (MGA) confirms the administration’s misguided reboot of the Rebate Rule would […]

ICYMI: STAT NEWS – NEW POLL SHOWS WIDE SUPPORT FOR SEVERAL TRUMP DRUG PRICING REFORMS, BUT NOT REBATE CHANGES

08-28-2020 Blog Posts

Administration Should Shelve Rebate Rule That Would Increase Medicare Premiums, Cost Taxpayers $200 Billion and Hand Big Pharma a Massive Bailout In case you missed it, a new poll first reported by STAT News on Friday highlights how the “Rebate Rule is the Achilles Heel of the president’s drug pricing agenda.” The survey found the […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.